Follow
CombiGene AB
Nasdaq First North Sweden (Sweden)
CombiGene AB is a gene therapy explorer based in Sweden. The company is engaged in developing new methods for the treatment of neurological diseases and for epileptic patients who cannot be helped by available medical treatments at present.
Sector:
HEALTH CARE
>
Biotechnology
Sector:
TECHNOLOGY
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
COMBI
SE0006504593
Nasdaq First North Sweden
Sweden (SE)
Details of share in CombiGene AB with ticker COMBI
Status
Active
Order book id
4133
Amount of instruments
65 053 647
Par value
0.1000
Market cap
Currency
SEK
Segment
First North
First trading date
25 May 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
5.00 SEK
44.2M SEK
08 Apr - 22 Apr 2015
IPO in CombiGene AB
Market
Spotlight
Subscription period
08 Apr - 22 Apr 2015
Subscription price
10.00 SEK
Price per share
5.00 SEK
Target to raise
12 500 000 SEK
Types
Pre-money valuation
44 200 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
First trading date
25 May 2015
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
Exercise
7.50 SEK
-
12 Oct - 21 Oct 2015
08 Feb - 17 Feb 2016
-
Option exercise terms for COMBI TO 1
Market
Spotlight
Exercise period(s)
12 Oct - 21 Oct 2015
08 Feb - 17 Feb 2016
Exercise price
7.50 SEK
Status
Closed
Issue terms
Type
Price
Pre-money valuation
Time
Files
New issue
3.00 SEK
35.4M SEK
06 Feb - 20 Feb 2017
Share issue in CombiGene AB
Market
Spotlight
Subscription period
06 Feb - 20 Feb 2017
Subscription price
Price per share
3.00 SEK
Target to raise
14 200 000 SEK
Types
Share issue
Pre-money valuation
35 400 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 2:5. For each existing share on the record date, one (1) subscription right is received. Five (5) subscription rights entitle to subscribe for two (2) new shares
Type
Price
Pre-money valuation
Time
Files
New issue
3.40 SEK
56.1M SEK
12 Feb - 28 Feb 2018
Share issue in CombiGene AB
Market
Spotlight
Subscription period
12 Feb - 28 Feb 2018
Subscription price
Price per share
3.40 SEK
Target to raise
10 200 000 SEK
Types
Share issue
Pre-money valuation
56 100 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preferential right 2:11. For each existing share on the record date, one (1) subscription right is received. Eleven (11) subscription rights entitle to subscribe for two (2) new shares
Type
Price
Pre-money valuation
Time
Files
New issue
0.90 SEK
15.5M SEK
04 Sep - 18 Sep 2018
Share issue in CombiGene AB
Market
Spotlight
Subscription period
04 Sep - 18 Sep 2018
Subscription price
9.00 SEK
Price per share
0.90 SEK
Target to raise
31 000 000 SEK
Types
Share issue
Pre-money valuation
15 500 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 2:1. Shareholders in the Company have preferential rights to subscribe for one (1) unit, consisting of ten (10) new shares and two (2) free warrants of series 2018/2019, for each five (5) existing shares held on the record date on August 30, 201
Type
Price
Pre-money valuation
Time
Files
Market move
19 Dec 2018
-
Listing of CombiGene AB on Nasdaq First North Sweden
Move from
Spotlight
Move to
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
CombiGene AB changed it's listing from Spotlight (previously AktieTorget) to Nasdaq First North Sweden. The first trading day for the instrument(s) on Nasdaq First North Sweden was the 19th of December 2018.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.00-2.50 SEK
-
15 Aug - 28 Aug 2019
01 Sep - 30 Sep 2019
Option exercise terms for COMBI TO 2
Market
Nasdaq First North Sweden
Exercise period(s)
15 Aug - 28 Aug 2019
01 Sep - 30 Sep 2019
Exercise price range
2.00-2.50 SEK
Exercise final price
Status
Closed
Issue terms
1 subscription option (COMBI TO 2) gives the holder the right to subscribe for 1 (one) new share. The price per share is set as 70 % of the volume weighted average market price during 15th-28th of August 2019, but at least 2.00 SEK and max 2.50 SEK.
Type
Price
Pre-money valuation
Time
Files
New issue
1.13 SEK
24 Oct 2019
-
Share issue in CombiGene AB
Market
Nasdaq First North Sweden
Subscription date
24 Oct 2019
Subscription price
Price per share
1.13 SEK
Target to raise
1 499 999 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed share issue to Lipigon Pharmaceuticals.
Comments for offer & related information
Type
Price
Pre-money valuation
Time
Files
New issue
0.50 SEK
32.53M SEK
20 Mar - 03 Apr 2020
Share issue in CombiGene AB
Market
Nasdaq First North Sweden
Subscription period
20 Mar - 03 Apr 2020
Subscription price
1.00 SEK
Price per share
0.50 SEK
Target to raise
32 530 000 SEK
Types
Share issue
Pre-money valuation
32 530 000 SEK
Subscription block size
Minimum subscription
Record date
18 Mar 2020
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 1:1. Two (2) existing shares held on the record date entitle the holder to subscribe for one (1) unit. Each unit consists of two (2) newly issued shares, one (1) subscription option of series TO1 and one (1) subscription option of series TO2.
Comments for offer & related information
The company shall issue a maximum of 65 053 647 shares. Subscription commitments and issue guarantees of SEK 26 million, corresponding to 80% of the Rights Issue, have been obtained from external guarantors and the company's Board of Directors. The rights issue includes an over-allotment option of a maximum of 4.95 million shares (MSEK 2.48), which is directed to the issue guarantors who may choose to offset part of the agreed guarantee commission.
The warrants are issued without consideration. TO3 expires in August 2020 and TO4 expires in November 2020. The subscription price is determined with the guidance of 10 trading days volume-weighted average price (VWAP) before the redemption with a discount of 30 percent, but at least SEK 0.4 and a maximum of SEK 0.6 for TO3 respectively. a minimum of SEK 0.5 and a maximum of SEK 0.7 for TO4.

Type
Ticker
ISIN
Market
OPTION
COMBI TO3
SE0014111308
Nasdaq First North Sweden
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO3
Status
Inactive
Order book id
Amount of instruments
32 526 823
Market cap
Currency
SEK
First trading date
Terms
The subscription price is determined with the guidance of 10 trading days volume-weighted average price (VWAP) before the redemption with a discount of 30 percent, but at least SEK 0.4 and a maximum of SEK 0.6
Type
Price
Pre-money valuation
Time
Files
Exercise
0.40-0.60 SEK
-
17 Aug - 31 Aug 2020
Option exercise terms for COMBI TO3
Market
Nasdaq First North Sweden
Exercise period(s)
17 Aug - 31 Aug 2020
Exercise price range
0.40-0.60 SEK
Exercise final price
Status
Upcoming
Issue terms
The subscription price is determined with the guidance of 10 trading days volume-weighted average price (VWAP) before the redemption with a discount of 30 percent, but at least SEK 0.4 and a maximum of SEK 0.6
Type
Ticker
ISIN
Market
OPTION
COMBI TO4
SE0014111316
Nasdaq First North Sweden
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO4
Status
Inactive
Order book id
Amount of instruments
32 526 823
Market cap
Currency
SEK
First trading date
Terms
The subscription price is determined with the guidance of 10 trading days volume-weighted average price (VWAP) before the redemption with a discount of 30 percent, but at least SEK 0.5 and a maximum of SEK 0.7.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.50-0.70 SEK
-
16 Nov - 30 Nov 2020
Option exercise terms for COMBI TO4
Market
Nasdaq First North Sweden
Exercise period(s)
16 Nov - 30 Nov 2020
Exercise price range
0.50-0.70 SEK
Exercise final price
Status
Upcoming
Issue terms
The subscription price is determined with the guidance of 10 trading days volume-weighted average price (VWAP) before the redemption with a discount of 30 percent, but at least SEK 0.5 and a maximum of SEK 0.7.
Type
Ticker
ISIN
Market
SHARE
COMBI
SE0006504593
Nasdaq First North Sweden
Sweden (SE)
Details of share in CombiGene AB with ticker COMBI
Status
Active
Order book id
4133
Amount of instruments
65 053 647
Par value
0.1000
Market cap
Currency
SEK
Segment
First North
First trading date
25 May 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
5.00 SEK
44.2M SEK
08 Apr - 22 Apr 2015
IPO in CombiGene AB
Market
Spotlight
Subscription period
08 Apr - 22 Apr 2015
Subscription price
10.00 SEK
Price per share
5.00 SEK
Target to raise
12 500 000 SEK
Types
Pre-money valuation
44 200 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
First trading date
25 May 2015
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
New issue
3.00 SEK
35.4M SEK
06 Feb - 20 Feb 2017
Share issue in CombiGene AB
Market
Spotlight
Subscription period
06 Feb - 20 Feb 2017
Subscription price
Price per share
3.00 SEK
Target to raise
14 200 000 SEK
Types
Share issue
Pre-money valuation
35 400 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 2:5. For each existing share on the record date, one (1) subscription right is received. Five (5) subscription rights entitle to subscribe for two (2) new shares
Type
Price
Pre-money valuation
Time
Files
New issue
3.40 SEK
56.1M SEK
12 Feb - 28 Feb 2018
Share issue in CombiGene AB
Market
Spotlight
Subscription period
12 Feb - 28 Feb 2018
Subscription price
Price per share
3.40 SEK
Target to raise
10 200 000 SEK
Types
Share issue
Pre-money valuation
56 100 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preferential right 2:11. For each existing share on the record date, one (1) subscription right is received. Eleven (11) subscription rights entitle to subscribe for two (2) new shares
Type
Price
Pre-money valuation
Time
Files
New issue
0.90 SEK
15.5M SEK
04 Sep - 18 Sep 2018
Share issue in CombiGene AB
Market
Spotlight
Subscription period
04 Sep - 18 Sep 2018
Subscription price
9.00 SEK
Price per share
0.90 SEK
Target to raise
31 000 000 SEK
Types
Share issue
Pre-money valuation
15 500 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 2:1. Shareholders in the Company have preferential rights to subscribe for one (1) unit, consisting of ten (10) new shares and two (2) free warrants of series 2018/2019, for each five (5) existing shares held on the record date on August 30, 201
Type
Price
Pre-money valuation
Time
Files
Market move
19 Dec 2018
-
Listing of CombiGene AB on Nasdaq First North Sweden
Move from
Spotlight
Move to
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
CombiGene AB changed it's listing from Spotlight (previously AktieTorget) to Nasdaq First North Sweden. The first trading day for the instrument(s) on Nasdaq First North Sweden was the 19th of December 2018.
Type
Price
Pre-money valuation
Time
Files
New issue
1.13 SEK
24 Oct 2019
-
Share issue in CombiGene AB
Market
Nasdaq First North Sweden
Subscription date
24 Oct 2019
Subscription price
Price per share
1.13 SEK
Target to raise
1 499 999 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed share issue to Lipigon Pharmaceuticals.
Comments for offer & related information
Type
Price
Pre-money valuation
Time
Files
New issue
0.50 SEK
32.53M SEK
20 Mar - 03 Apr 2020
Share issue in CombiGene AB
Market
Nasdaq First North Sweden
Subscription period
20 Mar - 03 Apr 2020
Subscription price
1.00 SEK
Price per share
0.50 SEK
Target to raise
32 530 000 SEK
Types
Share issue
Pre-money valuation
32 530 000 SEK
Subscription block size
Minimum subscription
Record date
18 Mar 2020
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 1:1. Two (2) existing shares held on the record date entitle the holder to subscribe for one (1) unit. Each unit consists of two (2) newly issued shares, one (1) subscription option of series TO1 and one (1) subscription option of series TO2.
Comments for offer & related information
The company shall issue a maximum of 65 053 647 shares. Subscription commitments and issue guarantees of SEK 26 million, corresponding to 80% of the Rights Issue, have been obtained from external guarantors and the company's Board of Directors. The rights issue includes an over-allotment option of a maximum of 4.95 million shares (MSEK 2.48), which is directed to the issue guarantors who may choose to offset part of the agreed guarantee commission.
The warrants are issued without consideration. TO3 expires in August 2020 and TO4 expires in November 2020. The subscription price is determined with the guidance of 10 trading days volume-weighted average price (VWAP) before the redemption with a discount of 30 percent, but at least SEK 0.4 and a maximum of SEK 0.6 for TO3 respectively. a minimum of SEK 0.5 and a maximum of SEK 0.7 for TO4.

Type
Ticker
ISIN
Market
OPTION
COMBI TO 1
SE0006510178
Nasdaq First North Sweden
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO 1
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Files
Exercise
7.50 SEK
-
12 Oct - 21 Oct 2015
08 Feb - 17 Feb 2016
-
Option exercise terms for COMBI TO 1
Market
Spotlight
Exercise period(s)
12 Oct - 21 Oct 2015
08 Feb - 17 Feb 2016
Exercise price
7.50 SEK
Status
Closed
Issue terms
Type
Ticker
ISIN
Market
OPTION
COMBI TO 2
SE0011616408
Nasdaq First North Sweden
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO 2
Status
Archived
Order book id
4NUT
Amount of instruments
6 879 130
Market cap
Currency
SEK
Segment
First North
First trading date
31 Oct 2018
Terms
1 subscription option (COMBI TO 2) gives the holder the right to subscribe for 1 (one) new share. The price per share is set as 70 % of the volume weighted average market price during 15th-28th of August 2019, but at least 2.00 SEK and max 2.50 SEK.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.00-2.50 SEK
-
15 Aug - 28 Aug 2019
01 Sep - 30 Sep 2019
Option exercise terms for COMBI TO 2
Market
Nasdaq First North Sweden
Exercise period(s)
15 Aug - 28 Aug 2019
01 Sep - 30 Sep 2019
Exercise price range
2.00-2.50 SEK
Exercise final price
Status
Closed
Issue terms
1 subscription option (COMBI TO 2) gives the holder the right to subscribe for 1 (one) new share. The price per share is set as 70 % of the volume weighted average market price during 15th-28th of August 2019, but at least 2.00 SEK and max 2.50 SEK.
Type
Ticker
ISIN
Market
OPTION
COMBI TO3
SE0014111308
Nasdaq First North Sweden
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO3
Status
Inactive
Order book id
Amount of instruments
32 526 823
Market cap
Currency
SEK
First trading date
Terms
The subscription price is determined with the guidance of 10 trading days volume-weighted average price (VWAP) before the redemption with a discount of 30 percent, but at least SEK 0.4 and a maximum of SEK 0.6
Type
Price
Pre-money valuation
Time
Files
Exercise
0.40-0.60 SEK
-
17 Aug - 31 Aug 2020
Option exercise terms for COMBI TO3
Market
Nasdaq First North Sweden
Exercise period(s)
17 Aug - 31 Aug 2020
Exercise price range
0.40-0.60 SEK
Exercise final price
Status
Upcoming
Issue terms
The subscription price is determined with the guidance of 10 trading days volume-weighted average price (VWAP) before the redemption with a discount of 30 percent, but at least SEK 0.4 and a maximum of SEK 0.6
Type
Ticker
ISIN
Market
OPTION
COMBI TO4
SE0014111316
Nasdaq First North Sweden
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO4
Status
Inactive
Order book id
Amount of instruments
32 526 823
Market cap
Currency
SEK
First trading date
Terms
The subscription price is determined with the guidance of 10 trading days volume-weighted average price (VWAP) before the redemption with a discount of 30 percent, but at least SEK 0.5 and a maximum of SEK 0.7.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.50-0.70 SEK
-
16 Nov - 30 Nov 2020
Option exercise terms for COMBI TO4
Market
Nasdaq First North Sweden
Exercise period(s)
16 Nov - 30 Nov 2020
Exercise price range
0.50-0.70 SEK
Exercise final price
Status
Upcoming
Issue terms
The subscription price is determined with the guidance of 10 trading days volume-weighted average price (VWAP) before the redemption with a discount of 30 percent, but at least SEK 0.5 and a maximum of SEK 0.7.
People
Number of Employees
3 people
Jan Nilsson
CEO
Arne Ferstad
Chairman of the board
Morten Albrechtsen
Board member
Arne Ferstad
Board member
Peter Nilsson
Board member
Lars Thunberg
Board member
Susana Ayesa Alvarez
Board member
Company Details
Sector
HEALTH CARE, TECHNOLOGY

Address
MEDICON VILLAGE
Zip code
223 81
City/district
LUND
Country
Sweden (SE)
Phones
Registration number
556403-3818
LEI code
213800CITFPHX4TL8G93
First trade date
25 May 2015
Registration date
03 Oct 1990
Short name
CombiGene

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date